Logo for ProMIS Neurosciences Inc

ProMIS Neurosciences Investor Relations Material

Latest events

Logo for ProMIS Neurosciences

Q4 2024

31 Mar, 2025
Logo for ProMIS Neurosciences

Q3 2024

13 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from ProMIS Neurosciences Inc

Access all reports
ProMIS Neurosciences Inc is a Canada-based biotechnology company focused on the discovery and development of antibody therapeutics for neurodegenerative diseases. The company uses a proprietary computational platform to design monoclonal antibodies that selectively target toxic misfolded proteins implicated in conditions such as Alzheimer's disease, amyotrophic lateral sclerosis (ALS), and Parkinson's disease. ProMIS conducts preclinical and early-stage clinical development in collaboration with academic and industry partners. The company is headquartered in Toronto, Ontario, and its shares are listed on the TSX.